Doramectin 117704-25-3 | Veterinary Antiparasitic API Supplier

Doramectin: Avermectin Endectocide for Livestock

Doramectin is a third-generation avermectin produced by mutational biosynthesis from Streptomyces avermitilis. Like other avermectins, it binds to glutamate-gated chloride channels in parasite nerve and muscle tissue, causing irreversible paralysis and death. Doramectin has a longer duration of action than ivermectin due to higher lipophilicity and depot effect at the injection site.

Product Profile

CAS Number 117704-25-3
Molecular Formula C50H74O14
Appearance White to yellowish powder
Therapeutic Category Veterinary Endectocide
Storage Store at controlled room temperature, protect from light

Applications

Doramectin is indicated for the treatment and control of gastrointestinal nematodes, lungworms, eyeworms, grubs (cattle), lice, and mange mites in cattle and swine. It is administered as a subcutaneous or intramuscular injection at 200 mcg/kg body weight, with a single dose providing extended protection due to sustained tissue concentrations. In cattle, it also controls Hypoderma larvae (warbles) and Dermatobia hominis. Doramectin is not approved for use in dairy cattle of breeding age in most markets due to withdrawal period considerations.

Why Source from TCS

TCS supplies doramectin to veterinary pharmaceutical companies across Europe and globally. Flexible order quantities from development samples to commercial volumes. Contact us with your target market and project requirements for a tailored quotation.

FAQ

What information should be included in an inquiry for Doramectin 117704-25-3?

A useful inquiry normally includes the product name, target application, estimated quantity, destination market, and any specific documentation or packaging requests.

How is Doramectin 117704-25-3 usually evaluated for sourcing?

This product is positioned for pharmaceutical sourcing discussions covering development, pilot, or commercial demand, subject to the buyer confirming application scope, market, and document requirements.

What documentation and commercial points are commonly reviewed before buying Doramectin 117704-25-3?

For pharmaceutical API procurement, buyers commonly align on specification review, target market, batch or annual demand, packaging expectations, and the documentation package needed for the project.

Request a Quote

If your team already has a target application, estimated quantity, destination market, or documentation requirements, send those details so the commercial response can be prepared more efficiently.

Contact the Commercial Team

Scroll to Top